Patents by Inventor Diana L. Blithe

Diana L. Blithe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Progestin/testosterone transdermal gel
    Patent number: 12502395
    Abstract: The present disclosure relates to a specific combination of a progestin and testosterone in a transdermal composition and usage thereof in a method for ensuring male contraception with more efficacy and less side effects.
    Type: Grant
    Filed: November 8, 2024
    Date of Patent: December 23, 2025
    Assignees: The Population Council, Inc., The United States of America, as rep'd by the Secy., Dept. of Health and Human Services
    Inventors: Diana L. Blithe, Min S. Lee, Regine Sitruk-Ware
  • Progestin/Testosterone Transdermal Gel
    Publication number: 20250064832
    Abstract: The present disclosure relates to a specific combination of a progestin and testosterone in a transdermal composition and usage thereof in a method for ensuring male contraception with more efficacy and less side effects.
    Type: Application
    Filed: November 8, 2024
    Publication date: February 27, 2025
    Applicants: The Population Council, Inc., The United States of America, as rep'd by the Secy., Dept. of Health and Human Services
    Inventors: Diana L. Blithe, Min S. Lee, Regine Sitruk-Ware
  • Natural human chorionic gonadotropin .beta.-core molecule
    Patent number: 5674983
    Abstract: The present invention relates to the purification of the human chorionic gonadotropin .beta.-core molecule which can then be used as the antigen in the preparation of antibodies to the .beta.-core molecule. The combination of the purified .beta.-core molecule and the antibodies can be used in an immunoassay kit to measure .beta.-core molecules in the presence of structurally similar molecules, i.e., hCG, LH, hCG.beta.-subunit and LH.beta.-subunit. Measurement of the .beta.-core molecule is particularly useful in testing for pregnancy and many malignancies.
    Type: Grant
    Filed: May 23, 1995
    Date of Patent: October 7, 1997
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Diana L. Blithe, Robert E. Wehmann, Bruce C. Nisula